Physicians affiliated with 67 U.S. healthcare organizations, including leading academic medical centers and children's hospitals, now refer patients to Evinature's digital patient support platform, bringing personalized supplement plans, dedicated guidance, and ongoing follow-up together in one place.
WILMINGTON, Del., Oct. 27, 2026 /PRNewswire-PRWeb/ -- Evinature, a spin-off of Sheba Medical Center that combines a digital patient engagement platform with personalized nutritional support, today announced that physicians affiliated with 67 healthcare organizations across the United States now refer patients to its digital patient support platform.
Referring physicians include those affiliated with New York Gastroenterology Associates (NYGA), Children's Hospital Los Angeles, and Ann & Robert H. Lurie Children's Hospital of Chicago. The physician referral network spans academic medical centers, children's hospitals, health systems, and gastroenterology practices.
A Digital Platform Built Around Ongoing Support
Evinature's platform combines digital assessments, personalized supplement plans, and regular follow-up, with a dedicated support team available to provide guidance and answer questions. Follow-up assessments help inform adjustments to each plan as patients' needs change. Referring healthcare providers can also access the support team, research, and formulation information.
"Patients need more than a product. They need clear guidance, someone to answer their questions, and support that adapts as their needs change," said Nir Salomon, CEO of Evinature and founder and director of the Integrative Gastroenterology Unit at Sheba Medical Center. "That is what our platform is built to do. As more physicians refer patients to us, our focus is on making the next steps straightforward for both patients and their healthcare providers."
A Research-Led Foundation
Evinature was co-founded by Salomon and Professor Shomron Ben-Horin, MD, Chief Medical Officer of Evinature and Chief of the Gastroenterology Department at Sheba Medical Center. CurQD®, Evinature's flagship supplement formulation, has been investigated in a randomized, double-blind, placebo-controlled trial, with additional pediatric studies and real-world evaluations.*
CurQD® has also been selected for a U.S. Department of Defense-funded clinical trial led by researchers at Mount Sinai, the University of Chicago Medicine, and Sheba Medical Center.
About Evinature
Evinature is a digestive health company offering a digital patient support platform that combines personalized supplement plans with ongoing guidance from a dedicated support team. Regular follow-up assessments help inform adjustments as individuals' needs change.
For further information, visit the company's website at evinature.com.
* The formulation referenced is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Media Contact
Danielle Max, Evinature, 1 (612) 261 0298, [email protected], evinature.com
SOURCE Evinature
Share this article